Autism Spectrum Disorder
Cluster Number:
Wiki Number: W017
Diagnosis: Autism Spectrum Disorder
US Patients: 1.5Mil
World Patients: 62Mil
Sex Ratio: 4B;1G
Age Onset: By 1
Brain Area: Enlarged frontal and temporal lobes, mirrror neurons, corpus callosum
Symptoms: poor communication, repetitive behaviors
Progression: delayed language & cognitive development; 50% head banging, self-biting;10% savants
Causes: 75% genetic from 1000 genes; not enough GABA, less brain connectivity between regions
Medications: risperdone
Therapies: earlier, the better; teach coping skills, awareness of others’ presence, interests
Youtube Video: Meet the Experts:
Autism Explained: A Guide to Autism
Amazon or Library Book: Kids With Autism Spectrum Disorder
Amazon or Library Book: Parenting a Child with Autism
Click the book to link or order from Amazon.
Click the book to link or order from Amazon.
Contact your school for Special Education under the
U.S. Department of Education’s Individuals with
Disabilities Education Act, Section 300.8.
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services, Section12.10.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosisÂ
Clicking each title opens the
PubMed article’s summary-abstract.
- Association between maternal antidepressant use during pregnancy and the risk of autism spectrum disorder and attention deficit hyperactivity disorder in offspringby Min-Jing Lee on May 19, 2024
Prenatal antidepressant exposure has been reported to be associated with adverse neurodevelopmental outcomes, yet studies considering confounding factors in Asian populations are lacking. This study utilized a nationwide data base in Taiwan, enrolling all liveborn children registered in the National Health Insurance system between 2004 and 2016. Subjects were divided into two groups: antidepressant-exposed (n = 55,707)) and antidepressant-unexposed group (n = 2,245,689). The effect of...
- Validity of the ESSENCE-Q neurodevelopmental screening tool in Japanby Kahoko Yasumitsu-Lovell on May 18, 2024
AIM: To assess the validity of the Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations-Questionnaire (ESSENCE-Q), a simple screening tool for neurodevelopmental problems, in Japan.
- Global Sensory Features are Linked to Executive and Attentional Impairments in Autism Spectrum Disordersby Pierre Augé on May 18, 2024
Sensory features, executive and attentional impairments are frequently reported in individuals with autism spectrum disorders (ASD). However, little is known about their complex relationships. In this study, we aim to examine the executive and attentional difficulties related to distinct sensory profiles. We identified sensory profiles with a Latent Profile Analysis (LPA) based on scores on the Short Sensory Profile (SSP) questionnaire in 95 children with ASD aged 6 to 17 years. Executive and...
- Amino Acid Transporters in Neurological Disorders and Neuroprotective Effects of Cysteine Derivativesby Santosh Kumar Adla on May 18, 2024
For most diseases and disorders occurring in the brain, the full causes behind them are yet unknown, but many show signs of dysfunction of amino acid transporters or abnormalities in amino acid metabolism. The blood-brain barrier (BBB) plays a key role in supporting the function of the central nervous system (CNS). Because of its unique structure, the BBB can maintain the optimal environment for CNS by controlling the passage of hydrophilic molecules from blood to the brain. Nutrients, such as...